Home  >> Transactions>> Harvard Bioscience has acquired Data Sciences International

Harvard Bioscience has acquired Data Sciences International

Harvard Bioscience, Inc. (Nasdaq:HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, has acquire 100% of the outstanding stock of Data Sciences International, Inc. (“DSI”) for approximately $70 million (subject to adjustment for net working capital and other customary adjustments).

DSI, a St. Paul, Minnesota-based life science research company, is a recognized leader in physiologic monitoring focused on delivering preclinical products, systems, services and solutions to its customers. Its customers include pharmaceutical and biotechnology companies, as well as contract research organizations, academic labs and government researchers. For the trailing 12 months (“TTM”) ended December 31, 2017, DSI had approximately $44 million in revenue.

EC M&A acted as financial advisor to Harvard Bioscience on this transaction

Others

Xylem has sold Sensus Precision Die Casting (Yangzhou) to SORL Auto Parts      Learn More >>
Randstad has sold Locum Medical Group to Health Carousel      Learn More >>
EMX Industries has been sold to Watervale      Learn More >>
Steel Partners has acquired PST Group      Learn More >>
Galileo TP has been sold to Burke Porter Group      Learn More >>
Entegris Has Acquired Flex Concepts, Inc.      Learn More >>
Hänsel Group has sold a majority stake to Possehl      Learn More >>
Entegris has acquired SAES Pure Gas Business from SAES Group      Learn More >>
Ldetek has been sold to Battery Ventures’ Process Sensing Technologies Group      Learn More >>
Axel Johnson International acquires MAK Aandrijvingen      Learn More >>
SPX has acquired CUES, Inc.      Learn More >>
Dickson Data has been sold to May River Capital      Learn More >>